CGEM
Cullinan Oncology LLC
NASDAQ: CGEM · HEALTHCARE · BIOTECHNOLOGY
$12.85
+0.31% today
Updated 2026-04-29
Market cap
$837.68M
P/E ratio
—
P/S ratio
25.86x
EPS (TTM)
$-3.36
Dividend yield
—
52W range
$6 – $17
Volume
0.8M
Cullinan Oncology LLC (CGEM) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |